
### [NCIT:C45250](http://purl.obolibrary.org/obo/NCIT_C45250)
**Label:** Cutaneous Mature T-Cell and NK-Cell Neoplasm

**Subclasses:** [NCIT:C3721](http://purl.obolibrary.org/obo/NCIT_C3721) (Lymphomatoid Papulosis), [NCIT:C3467](http://purl.obolibrary.org/obo/NCIT_C3467) (Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C8938](http://purl.obolibrary.org/obo/NCIT_C8938) (Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C3246](http://purl.obolibrary.org/obo/NCIT_C3246) (Mycosis Fungoides), [NCIT:C7805](http://purl.obolibrary.org/obo/NCIT_C7805) (Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C45340](http://purl.obolibrary.org/obo/NCIT_C45340) (Primary Cutaneous Gamma-Delta T-Cell Lymphoma), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C45366](http://purl.obolibrary.org/obo/NCIT_C45366) (Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder), [NCIT:C45268](http://purl.obolibrary.org/obo/NCIT_C45268) (Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C7195](http://purl.obolibrary.org/obo/NCIT_C7195) (Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C35794](http://purl.obolibrary.org/obo/NCIT_C35794) (Pagetoid Reticulosis), [NCIT:C6918](http://purl.obolibrary.org/obo/NCIT_C6918) (Subcutaneous Panniculitis-Like T-Cell Lymphoma), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C45271](http://purl.obolibrary.org/obo/NCIT_C45271) (Cutaneous Angioimmunoblastic T-Cell Lymphoma), [NCIT:C7798](http://purl.obolibrary.org/obo/NCIT_C7798) (Stage II Mycosis Fungoides), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C139014](http://purl.obolibrary.org/obo/NCIT_C139014) (Type D Lymphomatoid Papulosis), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C45332](http://purl.obolibrary.org/obo/NCIT_C45332) (Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), [NCIT:C139015](http://purl.obolibrary.org/obo/NCIT_C139015) (Type E Lymphomatoid Papulosis), [NCIT:C7197](http://purl.obolibrary.org/obo/NCIT_C7197) (Type A Lymphomatoid Papulosis), [NCIT:C7196](http://purl.obolibrary.org/obo/NCIT_C7196) (Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C7199](http://purl.obolibrary.org/obo/NCIT_C7199) (Type C Lymphomatoid Papulosis), [NCIT:C45339](http://purl.obolibrary.org/obo/NCIT_C45339) (Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma), [NCIT:C7198](http://purl.obolibrary.org/obo/NCIT_C7198) (Type B Lymphomatoid Papulosis), [NCIT:C39644](http://purl.obolibrary.org/obo/NCIT_C39644) (Mycosis Fungoides Variant), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40286](http://purl.obolibrary.org/obo/NCIT_C40286) (Vulvar Basaloid Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40284](http://purl.obolibrary.org/obo/NCIT_C40284) (Vulvar Keratinizing Squamous Cell Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40275](http://purl.obolibrary.org/obo/NCIT_C40275) (Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40272](http://purl.obolibrary.org/obo/NCIT_C40272) (Vaginal Undifferentiated Sarcoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40271](http://purl.obolibrary.org/obo/NCIT_C40271) (Low Grade Endometrioid Stromal Sarcoma of the Vagina))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 38.69%


